Back to search results

Indivi Mobile Application for Cognitive Performance in Aging

This study is looking at how well the Indivi mobile app works for monitoring thinking skills in people aged 50 to 90. It includes individuals with mild cognitive impairment (MCI) or mild Alzheimer's disease, as well as healthy controls. The app uses a special system that adjusts the difficulty of activities to each user. Researchers want to see if this system reaches a stable difficulty level at the same rate for everyone, and if that stable level is different for people with MCI/Alzheimer's compared to healthy individuals. The study aims to enroll 55 participants, but its current status is unclear.

Study design
This is an observational study, meaning participants will be monitored without receiving a specific intervention. It aims to include 55 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be monitored during the 6-week study period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07174869

A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

Completed
Not specifiedAges 50–90Observational
Indivi AG
~32 participants
Updated 2026-08-11 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of test iterations until stable difficulty level is reached
Measured over During the 6-week study period.
+1 more outcome measured

Conditions

Mild Cognitive Impairment (MCI)
Mild Alzheimer Disease

Explore related trials

Alzheimer's DiseaseMild cognitive disorder

Where it's being run

1 sites across 1 states
Massachusetts1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant is part of BU-ADRC cohort.
Participant is diagnosed with MCI, mild AD, or is classified as HC per BU-ADRC, with available required data for inclusion obtained less than 2 years before the inclusion.
Participant is between 50 and 90 years old, included.
Participant is able to use a smartphone.
Participant has sufficient knowledge of the English language.
Participant is able to and has an intention to follow the study procedures.
Informed Consent as documented by signature.

Exclusion

Participant has any neurological condition that may be contributing to cognitive impairment (above and beyond that caused by the subject's MCI or AD).
Participant has psychiatric diagnosis or symptoms, (e.g., hallucinations, major depression, or delusions) that could interfere with study procedures.
Participant has a history of stroke or seizures within the last 24 months.
Participant has a Geriatric Depression Scale (GDS) score ≥8.
Participant has a severe visual or hearing impairment that would interfere with capacity to perform cognitive assessments.
Known or suspected non-compliance.

What this trial measures

  • Number of test iterations until stable difficulty level is reachedDuring the 6-week study period.

    Stable difficulty level is defined as no increase in difficulty across 3 consecutive test iterations. Comparison will be made between PwMCI and HC.

  • Distribution of participants across assessment levels at steady-state difficultyDuring the 6-week study period

    Steady-state difficulty is defined as no increase in difficulty across 3 consecutive test iterations. The outcome will describe the distribution pattern of participants across the available assessment levels at steady-state.